What is William Blair’s Estimate for Cott Q3 Earnings?

Cott Corp. (TSE:PRM) – Equities researchers at William Blair issued their Q3 2024 earnings per share estimates for Cott in a research report issued on Tuesday, November 5th. William Blair analyst J. Andersen anticipates that the company will post earnings of $0.36 per share for the quarter. William Blair has a “Strong-Buy” rating on the stock. William Blair also issued estimates for Cott’s Q4 2024 earnings at $0.25 EPS and FY2025 earnings at $1.23 EPS.

Cott (TSE:PRM) last posted its earnings results on Thursday, August 8th. The company reported C$0.30 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.32 by C($0.02). The firm had revenue of C$663.59 million for the quarter, compared to analysts’ expectations of C$658.00 million.

Separately, Raymond James cut Cott from a “moderate buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.

Cott Stock Performance

Shares of Cott stock opened at C$13.20 on Friday. Cott has a 1 year low of C$13.15 and a 1 year high of C$14.97.

Cott Announces Dividend

The firm also recently disclosed a None dividend, which will be paid on Thursday, November 21st. Investors of record on Tuesday, November 5th will be paid a dividend of $1.109 per share. The ex-dividend date of this dividend is Tuesday, November 5th.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.